Meijer Sterile Saline Nasal Mist Recalled for Quality Control Issues
Product Quest Manufacturing LLC is recalling Meijer Sterile Saline Nasal Mist cans due to manufacturing deviations that could impact product quality.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The FDA classified this as a Class II recall, which typically involves a situation that could cause temporary or medically reversible health problems. The source text cites CGMP deviations that could impact product quality, representing a risk of harm where specific injuries have not yet been reported.
Plain-English summary
Product Quest Manufacturing LLC is recalling 37,464 cans of Meijer Sterile Saline Nasal Mist (0.9% Sodium Chloride Solution), 4.25 OZ (120 g). The product was distributed nationwide in the USA by Meijer Distribution, Inc. The recall includes all lots remaining within their expiry dates.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. These deviations indicate that the products were manufactured under conditions that could impact product quality. The FDA has classified this recall as Class II.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- Meijer, Sterile Saline Nasal Mist (0.9% Sodium Chloride Solution), 4.25 OZ (120 g) can, Dist. By Meijer Distribution, Inc., 2929 Walker Ave. NW, Grand Rapids, MI 49544, UPC 7 13733 27615 3.
- Manufacturer
- Product Quest Manufacturing LLC
- Category
- Drug — Nasal Spray
- Affected units
- 37,464
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 54 recalled by Product Quest Manufacturing LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · Product Quest Manufacturing LLC
See all →- ModeratePremier Value Sterile Saline Nasal Mist Recalled for Quality Concerns
FDA (Drugs) · 2018-10-24
- ModerateRhinall Nasal Decongestant Spray Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateRhinall Nasal Decongestant Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateCVS Health Saline Nasal Spray Recalled for Manufacturing Deviations
FDA (Drugs) · 2018-10-24
- ModerateRite Aid Nasal Spray Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
Same hazard · quality control
See all →- HighBaxter Recalls CARDENE IV Nicardipine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateMylan Recalls Mycophenolate Mofetil Injection Due to Dissolution Failures
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- CriticalMeijer Magnesium Citrate Laxative Recalled for Microbial Contamination
FDA (Drugs) · 2022-09-21
- ModerateDrug Recall: Purely Soothing MSM Nasal Spray due to manufacturing deviations
FDA (Drugs) · 2023-03-15
- ModerateNasal Decongestant Recalled for Possible Manufacturing Water Contamination
FDA (Drugs) · 2024-01-10
- ModerateOTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateOxymetazoline Nasal Spray Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateNasal Mist Oxymetazoline HCl Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02